Melinda Emig was appointed Executive Director of Business Development at Baim Institute for Clinical Research in October of 2022.  She is responsible for managing and maintaining client/sponsor relationships and well as building strategies for future opportunities.  She works with the operations and proposal teams to proactively identify current or upcoming clinical trial needs for present-day and prospective sponsors. She also communicates the preferences, specific functions, and services needed from the required study team and works with the Clients and Baim teams to identify strategies tailored for success on each opportunity.

Prior to Baim, Melinda began her career at Abbott Laboratories, then joined the clinical research industry in 1998, and has held various clinical research business development and clinical positions. She has extensive international experience in Business and Strategic Alliance Development as well as expertise in alliance building, negotiation and customer service process design and improvements.

 She has 20+ years of experience leading sales and international cross functional project teams and has worked extensively in the Biotechnology, Medical Device, and Pharmaceutical Industries. She is the recipient of multiple awards including Sales Excellence / Top Performer / Largest Award in Company History.

Melinda holds a bachelor’s degree in business administration from Kansas State University.